Facing federal policy uncertainty, declining research funding and a looming government shutdown, Duke School of Medicine leaders outlined a cautious — and optimistic — path forward in a Tuesday webinar. “The school continues to experience financial headwinds, consistent with our other academic peers and higher ed universities,” Hamby said. According to Elengold, Duke has filed 20 appeals for terminated grants, with partial victories but little resolution. Aside from the uncertainty surrounding NIH grants, Elengold also said that Duke is concerned about the potential cap on F&A reimbursement rates. Countering misinformation, federal loan capsKlotman also pointed to another investment she said the University community has a responsibility to make: countering misinformation.